NSE level in combined neuroendocrine and adenocarcinoma EGFR mutated lung cancer resistant to EGFR-TKI

被引：6
|
作者：
Facchinetti, Francesco [1 ]
Tiseo, Marcello [1 ]
Gnetti, Letizia [2 ]
Silini, Enrico Maria [2 ]
Ardizzoni, Andrea [1 ]
机构：
[1] Univ Hosp Parma, Med Oncol Unit, I-43100 Parma, Italy
[2] Univ Hosp Parma, Surg Pathol Unit, I-43100 Parma, Italy
来源：
LUNG CANCER | 2013年 / 82卷 / 01期
关键词：
CARCINOMA;
D O I：
10.1016/j.lungcan.2013.07.018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：177 / 178
页数：2
相关论文
共 39 条
  • [1] Epithelial-Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
    Uramoto, Hidetaka
    Iwata, Teruo
    Onitsuka, Takamitsu
    Shimokawa, Hidehiko
    Hanagiri, Takeshi
    Oyama, Tsunehiro
    ANTICANCER RESEARCH, 2010, 30 (07) : 2513 - 2517
  • [2] Rechallenge with EGFR-TKI after failure of immunotherapy is considered an effective treatment for advanced lung adenocarcinoma patients with EGFR exon 19 deletion: a case report
    Chen, Shubin
    Yu, Qitao
    Jiang, Wei
    Lu, Yukun
    Zhao, Yun
    Wang, Huilin
    FRONTIERS IN MEDICINE, 2023, 10
  • [3] Negative impact of ratio of the microvascular area to tumor area on the response to EGFR-TKI in non-small cell lung cancer with an EGFR mutation
    Anai, Moriyasu
    Saruwatari, Koichi
    Imamura, Kosuke
    Fujino, Kosuke
    Jodai, Takayuki
    Sakata, Shinya
    Iyama, Shinji
    Tomita, Yusuke
    Saeki, Sho
    Ichiyasu, Hidenori
    Ikeda, Koei
    Suzuki, Makoto
    Sakagami, Takuro
    JOURNAL OF THORACIC DISEASE, 2024, 16 (02) : 1151 - 1160
  • [4] Characterization of non-small cell lung cancer transforming to small cell lung cancer and its response to EGFR-TKI: a case report
    Fang, Guotao
    Liu, Weiwei
    Shang, Yanhong
    Huo, Ran
    Shi, Xiaoliang
    Wang, Yanan
    Li, Jinghua
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (02)
  • [5] Overcoming T790M mutant small cell lung cancer with the third-generation EGFR-TKI osimertinib
    Tang, Kejing
    Jiang, Neng
    Kuang, Yukun
    He, Qiong
    Li, Shuhua
    Luo, Jiping
    Jiang, Wenting
    Chen, Yangshan
    Sun, Yu
    Chen, Lili
    Chen, Yanyang
    Zhu, Junfeng
    Cui, Yongmei
    Wan, Han
    Ke, Zunfu
    THORACIC CANCER, 2019, 10 (02) : 359 - 364
  • [6] Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancer
    Ali, Azhar
    Levantini, Elena
    Teo, Jun Ting
    Goggi, Julian
    Clohessy, John G.
    Wu, Chan Shuo
    Chen, Leilei
    Yang, Henry
    Krishnan, Indira
    Kocher, Olivier
    Zhang, Junyan
    Soo, Ross A.
    Bhakoo, Kishore
    Chin, Tan Min
    Tenen, Daniel G.
    EMBO MOLECULAR MEDICINE, 2018, 10 (03)
  • [7] LncRNA SNHG15 regulates EGFR-TKI acquired resistance in lung adenocarcinoma through sponging miR-451 to upregulate MDR-1
    Huang, Jiayuan
    Pan, Banzhou
    Xia, Guohao
    Zhu, Jingni
    Li, Chenchen
    Feng, Jifeng
    CELL DEATH & DISEASE, 2020, 11 (07)
  • [8] EGFR-Mutated Squamous Cell Lung Cancer and Its Association With Outcomes
    Jin, Rui
    Peng, Ling
    Shou, Jiawei
    Wang, Jin
    Jin, Yin
    Liang, Fei
    Zhao, Jing
    Wu, Mengmeng
    Li, Qin
    Zhang, Bin
    Wu, Xiaoying
    Lan, Fen
    Xia, Lixia
    Yan, Junrong
    Shao, Yang
    Stebbing, Justin
    Shen, Huahao
    Li, Wen
    Xia, Yang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Continuing EGFR-TKI treatment in combination with super-selective arterial infusion chemotherapy beyond disease progression for patients with advanced EGFR-mutant non-small cell lung cancer
    Qi, Huiwei
    Jiang, Sen
    Yu, Dong
    Ni, Huijuan
    Hu, Qiong
    Zhang, Jie
    MEDICAL ONCOLOGY, 2015, 32 (12)
  • [10] Paired genomic analysis of squamous cell carcinoma transformed from EGFR-mutated lung adenocarcinoma
    Park, Sehhoon
    Shim, Joon Ho
    Lee, Boram
    Cho, Inju
    Park, Woong-Yang
    Kim, Youjin
    Lee, Se-Hoon
    Choi, Yoon La
    Han, Joungho
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    Sun, Jong-Mu
    LUNG CANCER, 2019, 134 : 7 - 15
1234